LogicMark, Inc. (LGMK)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch LGMK
See up to 3 months of LGMK. The 7-day demo opens the 1M and 3M ranges and puts LGMK on your watchlist.
Start 7-day demoLatest LGMK insider trades
About LogicMark, Inc. (LGMK)
LogicMark, Inc. files with the SEC under CIK 0001566826 and is classified as orthopedic, prosthetic and surgical appliances and supplies. It is grouped with Health Care companies on this site.
LGMK Form 4 activity by transaction type, last 90 days
No Form 4 activity for LGMK in the last 90 days.
LGMK insider transactions (Form 4)
3929 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Carine Schneider - Director | Grant or award | Options to Purchase | 667 footnote F1,F2 | $0.00 | - | |
| ||||||
 John P. Pettitt - Director | Grant or award | Options to Purchase | 667 footnote F1,F2 | $0.00 | - | |
| ||||||
| Robert Arthur Curtis - Director | Grant or award | Options to Purchase | 667 footnote F1,F2 | $0.00 | - | |
| ||||||
 Barbara Gutierrez - Director | Grant or award | Options to Purchase | 667 footnote F1,F2 | $0.00 | - | |
| ||||||
| Carine Schneider - Director | Grant or award | Options to Purchase | 20,833 footnote F1 | $0.00 | - | |
| ||||||
| Barbara Gutierrez - Director | Grant or award | Options to Purchase | 20,833 footnote F1 | $0.00 | - | |
| ||||||
| Robert Arthur Curtis - Director | Grant or award | Options to Purchase | 20,833 footnote F1 | $0.00 | - | |
| ||||||
| John P. Pettitt - Director | Grant or award | Options to Purchase | 20,833 footnote F1 | $0.00 | - | |
| ||||||
 Mark Archer - Officer | Grant or award | Common Stock | 23,750 footnote F2 | $0.00 | - | |
| Mark Archer - Officer | Grant or award | Common Stock | 1,250 footnote F2 | $0.00 | - | |
| ||||||
 Chia-Lin Simmons - Officer | Grant or award | Common Stock | 74,800 footnote F2 | $0.00 | - | |
| ||||||
| Carine Schneider - Director | Grant or award | Options to Purchase | 3,125,000 footnote F1 | $0.00 | - | |
| ||||||
| Barbara Gutierrez - Director | Grant or award | Options to Purchase | 3,125,000 footnote F1 | $0.00 | - | |
| ||||||
| Robert Arthur Curtis - Director | Grant or award | Options to Purchase | 3,125,000 footnote F1 | $0.00 | - | |
| ||||||
| John P. Pettitt - Director | Grant or award | Options to Purchase | 3,125,000 footnote F1 | $0.00 | - | |
| ||||||
| Carine Schneider - Director | Grant or award | Options to Purchase | 2,500,000 | $0.00 | - | |
| Barbara Gutierrez - Director | Grant or award | Options to Purchase | 2,500,000 | $0.00 | - | |
| Robert Arthur Curtis - Director | Grant or award | Options to Purchase | 2,500,000 | $0.00 | - | |
| John P. Pettitt - Director | Grant or award | Options to Purchase | 2,500,000 | $0.00 | - | |
| Mark Archer - Officer | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Mark Archer - Officer | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Chia-Lin Simmons - Officer | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Chia-Lin Simmons - Officer | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Carine Schneider - Director | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Carine Schneider - Director | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Barbara Gutierrez - Director | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Barbara Gutierrez - Director | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Robert Arthur Curtis - Director | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Robert Arthur Curtis - Director | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| John P. Pettitt - Director | Grant or award | Series A Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| John P. Pettitt - Director | Grant or award | Series B Common Stock Purchase Warrant | 4,851 | $0.13 | $606 | |
| Winvest Investment Fund Management Corp. - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 336,100 | $0.10 | $35K | |
| Winvest Investment Fund Management Corp. - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 380 | $0.09 | $36 | |
| Winvest Investment Fund Management Corp. - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 2,104,107 | $0.08 | $179K | |
| Winvest Investment Fund Management Corp. - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 1,024,400 | $0.09 | $93K | |
| Carine Schneider - Director | Grant or award | Options to Purchase | 64,516 | $0.00 | - | |
| Barbara Gutierrez - Director | Grant or award | Options to Purchase | 64,516 | $0.00 | - | |
| Robert Arthur Curtis - Director | Grant or award | Options to Purchase | 64,516 | $0.00 | - | |
| John P. Pettitt - Director | Grant or award | Options to Purchase | 64,516 | $0.00 | - | |
Item 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Item 5.07
Item 1.01, 9.01
Item 1.01, 3.02, 3.03, 5.02, 5.03, 9.01
LGMK insider trading FAQ
What is the latest insider trade for LGMK?
LogicMark, Inc. (LGMK) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-05. The full record for LGMK runs to 29 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LGMK stock?
No insider purchases of LGMK were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling LGMK stock?
No insider sales of LGMK were filed in the last 90 days.
Where can I see LGMK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LGMK Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Carine Schneider view on EDGAR
- - John P. Pettitt view on EDGAR
- - Robert Arthur Curtis view on EDGAR
- - Barbara Gutierrez view on EDGAR
- - Carine Schneider view on EDGAR
- - Barbara Gutierrez view on EDGAR
- - Robert Arthur Curtis view on EDGAR
- - John P. Pettitt view on EDGAR
- - Mark Archer view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LGMK's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LGMK with a 7-day demo
- LGMK on your watchlist
- Every LGMK Form 4 filing on record
- Up to 3 months of LGMK price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
